Icon

SERNIVO (nda208079)- (EQ 0.05% BASE/SPRAY)

BETAMETHASONE DIPROPIONATE PRIMUS PHARMS
EQ 0.05% BASE/SPRAY
Yes Yes
2030-Aug-31 Expired
None None
None No
SERNIVO Spray is a corticosteroid indicated for the treatment of mild to moderate plaque psoriasis in patients 18 years of age or older.
0 0 0
Total Other Developers None
Drugs with Suitability No
EQ 0.05% BASE/SPRAY ** ** - - -
NDA Sales Available Total Generic Sales Available
No 0
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country

GenUs Advanced Search




Expired
to
Expired
to


Please contact contact@researchdelta.com to get more details.